Angiosarcoma Project
@ASCaProject
A @count_me_in research initiative to partner directly w patients to accelerate and share discoveries in Angiosarcoma. Please follow us there for updates!
You might like
We are improving how and when we communicate so that you have more timely, clear messages that give you continuous information about the Angiosarcoma Project - as well as our other projects. Please follow us at @count_me_in to stay up to date with us.
Great to see this in print!!!!! Beautiful paper and the most extensive correlatives to date for sarcoma immunotherapy… congratulations to all the authors!
Nivolumab with bempegaldesleukin in sarcoma now published in @NatureComms. A collaborative effort with my colleagues @MSKSarcoma, @WTapMD, MSK computational biologists (Allison Richards, Mark Donoghue) and MDA colleagues @APConley77) nature.com/articles/s4146… @MSKCancerCenter 1/8
A reminder to please follow us at @count_me_in to stay up to date with us. Thank you!
We are improving how and when we communicate so that you have more timely, clear messages that give you continuous information about the Angiosarcoma Project - as well as our other projects. Please follow us at @count_me_in to stay up to date with us.
For those of you interested in learning more about a novel DoD funding mechanism for rare cancer research, please check out this free webinar, hosted by The NORD Rare Cancer Coalition on 5/2 rarediseases.zoom.us/webinar/regist…
CancerLinQ and @count_me_in announce a new collaboration that will democratize patient participation in cancer research by allowing more patients with cancer to contribute to cancer discoveries and propel progress against cancer. Learn more ➡️ fal.cn/3nxv1
So sad to hear about @virgilabloh another young life lost to #angiosarcoma #sarcomas @LouisVuitton @OffWht need more funding for #rarecancer #research @SarcomaAlliance @CureSarcoma @ASCaProject @AmColSurgCancer @ASCO
P140: GENOMIC & TRANSCRIPTOMIC CORRELATES OF RESP TO ICI BLOCKADE-BASED THERAPY FOR #ANGIOSARCOMA PTS #CTOS2021 Evan Rosenbaum, @sandrapdangelo et al ~1/3 pts w AS treated w ICI derived benefit, many (not all) pts w cutaneous/H&N tumors & UV signature. cdmcd.co/83yGjY
"Every patient's experience with cancer should be counted," Nikhil Wagle, M.D., director of Count Me In. To learn more about CMI's expansion to include all cancer pts in the US & CA, see our press release: tinyurl.com/CMIpress
Important #CancerTreatment progress for #Angiosarcoma from this @theNCI-funded study. Four of 16 patients partially or completely responded to treatment with a combo of #Immunotherapy drugs ipilimumab and nivolumab. Two other patients had stable disease >6 months. #RareCancers
New #JITC article: Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) @wagsmd @Dr_R_Kurzrock @EladSharonMD ow.ly/iPyA50FQd8L
Over 605 people have registered to participate in the Angiosarcoma Project since the project began. We have now received 276 saliva samples and 96 blood samples, and have obtained over 456 medical records and 218 tumor samples. ASCproject.org
#LCSM Chat Topic 6-May-2021: “The Hows and Whys of Cancer Research Advocacy” grayconnections.net/2021/05/04/lcs…
grayconnections.net
#LCSM Chat Topic 6-May-2021: “The Hows and Whys of Cancer Research Advocacy”
Please join #LCSM Chat and other Twitter cancer hashtag communities as we discuss “The Hows and Whys of Cancer Research Advocacy” on Twitter Thursday, May 6th, at 5 pm Pacific (8 pm Eas…
#RareDiseaseDay A great example of patient-partnered research that will enable therapeutic discoveries: nature.com/articles/s4159…
Patient-partnered research, such as the Angiosarcoma Project, has the potential to rapidly advance our understanding of #RareDiseases and how to treat them | #RareDiseaseDay @Nikhilwagle @ASCaProject @NatureMedicine ow.ly/UVeW50DL6pf
Michael Wagner, MD, of @fredhutch discusses responses achieved with nivolumab plus ipilimumab in patients with angiosarcoma. @wagsmd #scmsm ow.ly/pfWM50DvMhh
Broad, @DanaFarber, and @count_me_in launch research projects in two rare cancers, with focus on optimizing patient engagement; efforts aim to reveal rare cancer's genetic roots, mechanisms of drug resistance, and potential new treatment strategies. broad.io/CountMeIn021721
Angiosarcomas – past, present and future! breelynwilkymd.com/2021/01/31/ang…
breelynwilkymd.com
Angiosarcomas – past, present and future!
Good afternoon readers! Today’s blog post is devoted to a rare sarcoma, but one that is super important to recognize – it can often be mistaken for other things that are much more commo…
We have released another batch of data, bringing our numbers up to 83 clinically annotated WES samples from 62 patients. Please help us share this data both within the #sarcoma community and beyond to accelerate discoveries cbioportal.org/study/summary?…
If you haven't listened yet - here is just a lil snippet of our convo with the inspiring and yellow brick road builder @corrie_painter! Check out Ep. 6! #sarcoma #angiosarcoma #countmein traffic.libsyn.com/secure/sarcoma…
United States Trends
- 1. Nuss 3,243 posts
- 2. #AEWCollision 5,455 posts
- 3. Cam Coleman 3,494 posts
- 4. Lagway 1,863 posts
- 5. Vandy 5,418 posts
- 6. Iowa 30.3K posts
- 7. Auburn 14.7K posts
- 8. #UFCVegas111 12.2K posts
- 9. Ty Simpson 1,841 posts
- 10. Bama 10K posts
- 11. Oregon 38.3K posts
- 12. Ace Austin 1,317 posts
- 13. Wisconsin 18K posts
- 14. Bauer Sharp N/A
- 15. Dante Moore 3,790 posts
- 16. Kyle Fletcher 1,048 posts
- 17. Vanderbilt 4,258 posts
- 18. #Svengoolie 1,472 posts
- 19. Heisman 12.8K posts
- 20. #RollTide 3,728 posts
You might like
-
CTOS
@ctosociety -
SARC
@SARCtrials -
Breelyn Wilky, MD 🎗
@breelynwilkyMD -
Michael Wagner
@wagsmd -
Gladdy Lab
@GladdyLab -
Tom Wei-Wu Chen
@saxotomy -
Sarcoma Cancer Care Foundation
@CareSarcoma -
Palma Dileo
@dileo_palma -
Liz Connolly
@DrLizConnolly -
SPAGN
@sarcomapatients -
ANASTASIOS KYRIAZOGLOU
@AKyriazoglou -
The EHE Foundation
@EHEfoundation -
Anthony P Conley
@APConley77 -
EUROEWING Consortium
@euroewing -
Mikala Egeblad
@megeblad
Something went wrong.
Something went wrong.